ERBB2 and colorectal carcinoma: Conversely, mutations in Adenomatous polyposis coli (APC) and tumor protein p53 (TP53), as well as amplifications of Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) and EGFR, are more frequently observed in left-sided CRC [43].